- Today we celebrate the news that a new treatment for chronic Graft Vs Host Disease has been approved the National Institute for Health and Care Excellence (NICE). Belumosudil will…
- Over half of all stem cell transplant patients will experience some form of graft versus host disease (GvHD), a condition where donated cells start mistakenly attacking the…
- Anthony Nolan continues to invest in new blood cancer treatment innovations with a £1 million contribution to the new not-for-profit clinical trials organisation, ACT (…
- After having a stem cell transplant, Barry took on our 'Run 2km a Day' challenge. In this blog he shares his experience. The five hardest words I've ever had to…
- Living with MS I was diagnosed with MS in April 2021, but I think I’d had it for about 10 years. There were so many times I felt so tired, and I’d look at my mates who…
- Our researchers Anthony Nolan is launching its new research strategy, to help us provide the biggest impact possible for patients. Our researchers are at the heart of…
- 25 years of a crucial genetic resource This year marks the 25th year of operation of the world’s only centralised database of all the known variants of the HLA genes –…
- Improving the success of cord blood transplants Cord blood transplants are a potentially life-saving stem cell transplant option for many people who can’t find an ideal…
- Announcing new quality of life research Anthony Nolan is not the only big name celebrating its 50th birthday this year… The EBMT, a research organisation…
- You may have seen some stories in the news recently that suggest a stem cell transplant could either help treat, or even transmit, Alzheimer’s disease. We take a look at…